Effect of a thiol proteinase inhibitor, E-64-d, on susceptibility to infection with Staphylococcus aureus in Chediak-Higashi syndrome (beige) mice

International Immunopharmacology

Volumn 7, Issue 7, 2007, Pages 973-980

  Morimoto, Michiko ^a   Tanabe, Fuminori ^a   Kasai, Hirotake ^a   Ito, Masahiko ^a  

^a Interdisciplinary Graduate School of Medicine and Engineering   (Japan)

Author keywords

bacterial infection; beige mice; calpain; Chediak Higashi syndrome; protein kinase C

Indexed keywords

ALOXISTATIN; CALPAIN; CONCANAVALIN A; CYSTEINE PROTEINASE INHIBITOR; LYSOSOME ENZYME; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CAPPING PHENOMENON; CELL FUNCTION; CHEDIAK HIGASHI SYNDROME; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURVIVAL RATE;

ADMINISTRATION, ORAL; ANIMALS; BLOOD BACTERICIDAL ACTIVITY; CHEDIAK-HIGASHI SYNDROME; CYSTEINE PROTEINASE INHIBITORS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; LEUCINE; LYSOSOMES; MALE; MICE; MICE, INBRED C57BL; PROTEIN KINASE C; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE;

EID: 34247891585     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.03.004     Document Type: Article

References (36)

1. Chediak M. Nouvelle anomalie leukocytaire de caractere constitutionel et familiel. Rev Hematol 7 (1952) 362-367
2. Higashi O. Congenital gigantism of peroxidase granules. Tohoku J Exp Med 59 (1954) 315-332
3. Roder J.C., Haliotis T., Klein M., Kores S., Jett J.R., Ortaldo J., et al. A new immunodeficiency disorder in humans involving NK cells. Nature 284 (1980) 553-555
4. Jones K.L., Stewart R.M., Fowler M., Fukuda M., and Holcombe R.F. Chediak-Higashi lymphoblastoid cell lines: granule characteristics and expression of lysosome-associated membrane proteins. Clin Immunol Immunopathol 65 (1992) 219-226
5. Blume R.S., and Wolff S.M. The Chediak-Higashi syndrome: studies in four patients and a review of the literature. Medicine 51 (1972) 247-280 [Baltimore]
6. Clark R.A., and Kimball H.R. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest 50 (1971) 2645-2652
7. Gallin J.I., Klimerman J.A., and Padgett G.A. Defective mononuclear leukocyte chemotaxis in the Chediak-Higashi syndrome of humans, mink, and cattle. Blood 45 (1975) 863-870
8. Root R.K., Rosenthal A.S., and Balestra D.J. Abnormal bactericidal, metabolic and lysosomal functions of Chediak-Higashi syndrome leukocytes. J Clin Invest 51 (1972) 649-665
9. Gallin J.I., Elin R.J., Hubert R.T., Fauci A.S., Kaliner M.A., and Wolff S.M. Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice. Blood 53 (1979) 226-234
10. Barbosa M.D.F.S., Nguyen Q.A., Tchernev V.T., Ashley J.A., Detter J.C., Blaydes S.M., et al. Identification of the homologous beige and Chediak-Higashi syndrome gene. Nature 382 (1996) 262-265
11. Nagle D.L., Karim M.A., Woolf E.A., Holmgren L., Bork P., Misumi D.J., et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 14 (1996) 307-311
12. Barbosa M.D.F.S., Barrat F.J., Tchernev V.T., Nguyen Q.A., Mishra V.S., Colman S.D., et al. Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse. Hum Mol Genet 6 (1997) 1091-1098
13. Perou C.M., Leslie J.D., Green W., Li L., Ward D.M., and Kaplan J. The beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein. J Biol Chem 272 (1997) 29790-29794
14. Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science 225 (1984) 1365-1370
15. Ito M., Tanabe F., Takami Y., Sato A., and Shigeta S. Rapid down-regulation of protein kinase C in (Chediak-Higashi syndrome) beige mouse by phorbol ester. Biochem Biophys Res Commun 153 (1988) 648-656
16. Ito M., Sato A., Tanabe F., Ishida E., Takami Y., and Shigeta S. The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak-Higashi syndrome) beige mouse. Biochem Biophys Res Commun 160 (1989) 433-440
17. Tanabe F., Cui S.-H., and Ito M. Abnormal down-regulation of PKC is responsible for giant granule formation in fibroblasts from CHS (beige) mice-a thiol proteinase inhibitor, E-64-d, prevents giant granule formation in beige fibroblasts. J Leukoc Biol 67 (2000) 749-755
18. Sato A., Tanabe F., Ito M., Ishida E., and Shigeta S. Thiol proteinase inhibitors reverse the increased protein kinase C down-regulation and concanavalin A cap formation in polymorphonuclear leukocytes from Chediak-Higashi syndrome (beige) mice. J Leukoc Biol 48 (1990) 377-381
19. Tamai M., Matsumoto K., Omura S., Koyama I., Ozawa Y., and Hanada K. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E64. J Pharmacobiodyn 9 (1986) 672-677
20. Soon-Shiong P., and Grewal I.S. Enhancement of lectin-induced cap formation in human neutrophils by cyclosporin A. Biochem Biophys Res Commun 151 (1988) 435-440
21. Takeuchi K., Wood H., and Swank R.T. Lysosomal elastase and cathepsin G in beige mice: neutrophils of beige (Chediak-Higashi) mice selectively lack lysosomal elastase and cathepsin G. J Exp Med 163 (1986) 656-677
22. Barret A. Leukocyte elastase. Methods Enzymol 80 (1981) 581-588
23. Barret A., and Cathepsin G. Methods Enzymol 80 (1981) 561-588
24. Brandt E.J., Elliott R.W., and Swank R.T. Defective lysosomal enzyme secretion in kidneys of Chediak-Higashi (beige) mice. J Cell Biol 67 (1975) 774-788
25. Seigel S. Nonparametric statistics for the behavioral science (1956), McGraw-Hill, New York 116
26. Hanada K., Tamai M., Yamagishi M., Ohmura S., Sawada J., and Tanaka I. Isolation and characterization of E-64, a new thiol protease inhibitor. Agric Biol Chem 42 (1978) 523-528
27. Cui S.H., Tanabe F., Terunuma H., Iwatani Y., Nunoi H., Agematsu K., et al. A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leukocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity. Clin Exp Immunol 125 (2001) 283-290
28. Oliver J.M., Zurier R.B., and Berlin R.D. Concanavalin A cap formation on polymorphonuclear leukocytes of normal and beige (Chediak-Higashi) mice. Nature 253 (1975) 471-473
29. Oliver J.M. Cell biology of leukocyte abnormalities-membrane and cytoskeletal function in normal and defective cells. Am J Pathol 93 (1978) 221-259
30. Bourguignon L.Y.W., and Bourguignon G.J. Capping and the cytoskeleton. Int Rev Cytol 87 (1984) 195-224
31. Sato A., Tanabe F., Ito M., Ishida E., and Shigeta S. Protein kinase C inhibitors enhance concanavalin A cap formation in polymorphonuclear leukocytes. Int J Immunopharmacol 12 (1990) 121-125
32. Lindmark A., Gullberg U., and Olsson J. Processing and intracellular transport of cathepsin G and neutrophil elastase in the leukemic myeloid cell line U937-modulation by brefeldin A, ammonium chloride, and monensin. J Leukoc Biol 55 (1994) 50-57
33. Cavarra E., Martorana P.A., Cortese S., Cambelli F., Simplicio P.D., and Lungarella G. Neutrophils in beige mice secrete normal amounts of cathepsin G and a 46 kD latent form of elastase that can be activated extracellularly by proteolytic activity. Biol Chem 378 (1997) 417-423
34. Tanabe F., Cui S.H., and Ito M. Ceramide promotes calpain-mediated proteolysis of protein kinase Cβ in murine polymorphonuclear leukocytes. Biochem Biophys Res Commun 242 (1998) 129-133
35. Jogl G., Shen Y., Gebauer D., Li J., Wiegmann K., Kashkar H., et al. Crystal structure of the BEACH domain reveals an unusual fold and extensive association with a novel pH domain. EMBO J 21 (2002) 4785-4795
36. Ward D.M., Shiflett S.L., Huynh D., Vaughn M., Prestwich G., and Kaplan J. Use of expression constructs to dissect the functional domains of the CHS/Beige protein: identification of multiple phenotypes. Traffic 4 (2003) 403-415